The use of a series of ketamine infusions in two patients with treatment-resistant depression

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 22, Issue 4, 2010, Pages 442-444

  Messer, Michael ^a   Haller, Irina V ^a   Larson, Pamela ^a   Pattison Crisostomo, Julia ^a   Gessert, Charles E ^a  

^a SMDC Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE;

ADULT; AMNESIA; ARTICLE; BECK DEPRESSION INVENTORY; BODY WEIGHT; CASE REPORT; COGNITION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFECT; ELECTROCONVULSIVE THERAPY; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; PERCEPTION; PRIORITY JOURNAL; SUICIDAL IDEATION;

EID: 78149353393     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/jnp.2010.22.4.442     Document Type: Article

References (6)

1. Burrows GD, Norman TR, Judd FK: Definition and differential diagnosis of treatment-resistant depression. Int Clin Psychopharmacol 1994; 9(suppl 2):5-10
2. Paul IA, Skolnick P: Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 2003; 1003:250-272
3. Berman RM, Cappiello A, Anand A, et al: Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47:351-354
4. Correll GE, Futter GE: Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions. Pain Med 2006; 7:92-95
5. Zarate CA Jr, Singh JB, Carlson PJ, et al: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63:856-864
6. Leonard B: Clinical implications of mechanisms of action of antidepressants. Advances in Psychiatric Treatment 2000; 6:178-186